Cheng-Yi Sun

463 total citations
14 papers, 305 citations indexed

About

Cheng-Yi Sun is a scholar working on Molecular Biology, Cancer Research and Cognitive Neuroscience. According to data from OpenAlex, Cheng-Yi Sun has authored 14 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Cognitive Neuroscience. Recurrent topics in Cheng-Yi Sun's work include Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Cheng-Yi Sun is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Cheng-Yi Sun collaborates with scholars based in China. Cheng-Yi Sun's co-authors include Changhao Zhu, Zhiwei He, Jian Xu, Peng Chen, Xueyi Jiang, Jianxin Jiang, Jie Wang, Kun Cai, Shiyu Chen and Lin Li and has published in prestigious journals such as Cancer Letters, Cell Death and Disease and Transactions of the Royal Society of Tropical Medicine and Hygiene.

In The Last Decade

Cheng-Yi Sun

12 papers receiving 303 citations

Peers

Cheng-Yi Sun
Cheng-Yi Sun
Citations per year, relative to Cheng-Yi Sun Cheng-Yi Sun (= 1×) peers Rujuan Bao

Countries citing papers authored by Cheng-Yi Sun

Since Specialization
Citations

This map shows the geographic impact of Cheng-Yi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-Yi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-Yi Sun more than expected).

Fields of papers citing papers by Cheng-Yi Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-Yi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-Yi Sun. The network helps show where Cheng-Yi Sun may publish in the future.

Co-authorship network of co-authors of Cheng-Yi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-Yi Sun. A scholar is included among the top collaborators of Cheng-Yi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-Yi Sun. Cheng-Yi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Guo, Yuting, et al.. (2024). Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA1522. Asia-Pacific Journal of Clinical Oncology. 20(3). 423–432. 2 indexed citations
4.
Sun, Cheng-Yi, et al.. (2023). Placebo response of sham acupuncture in patients with primary dysmenorrhea: A meta-analysis. Journal of Integrative Medicine. 21(5). 455–463. 3 indexed citations
6.
Chen, Shiyu, Kun Cai, Changhao Zhu, et al.. (2022). Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. Cell Death and Disease. 13(3). 232–232. 24 indexed citations
7.
Cai, Kun, Shiyu Chen, Changhao Zhu, et al.. (2022). FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Cell Death and Disease. 13(9). 765–765. 59 indexed citations
8.
Wang, Jie, Changhao Zhu, Jian Xu, et al.. (2022). Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Letters. 548. 215751–215751. 137 indexed citations
9.
Wu, Chunchen, et al.. (2022). circACTG1 Promotes Hepatocellular Carcinoma Progression by Regulating miR-940/RIF1 Axis and Activating AKT/mTOR Pathway. Journal of Immunology Research. 2022. 1–13. 6 indexed citations
10.
Sun, Cheng-Yi. (2021). Current status of immunotherapy for pancreatic cancer. World Chinese Journal of Digestology. 29(20). 1151–1157. 2 indexed citations
11.
Sun, Cheng-Yi, et al.. (2021). HMGN5 promotes invasion and migration of colorectal cancer through activating FGF/FGFR pathway.. PubMed. 25(3). 1330–1338. 5 indexed citations
12.
Sun, Cheng-Yi & Yaozhen Pan. (2008). Advances in pathogenesis of hyperlipidemic acute pancreatitis and its diagnosis and treatment. World Chinese Journal of Digestology. 16(4). 343–343. 2 indexed citations
13.
Sun, Cheng-Yi, et al.. (2002). Expression of the bcl-2 gene and its significance in human pancreatic carcinoma.. PubMed. 1(2). 306–8. 20 indexed citations
14.
Wu, Chia‐Yi, et al.. (1979). Medical and surgical treatment in a case of amoebiasis of the left lung. Transactions of the Royal Society of Tropical Medicine and Hygiene. 73(4). 467–468.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026